The effect of comorbidity on use of thrombolysis or aspirin in patients with acute myocardial infarction eligible for treatment

Journal of General Internal Medicine

Volumn 12, Issue 1, 1997, Pages 1-6

  McLaughlin, Thomas J ^a   Soumerai, Stephen B ^a   Willison, Donald J ^b   Gurwitz, Jerry H ^c   Gao, Xiaoming ^a   Borbas, Catherine ^d   Gobel, Frederick ^e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Hlthcare Educ and Res Foundation   (United States)

^e Minneapolis (Minn) Heart Institute   (United States)

Author keywords

acute myocardial infarction; comorbidity; drug treatment; quality of care

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; RETROSPECTIVE STUDY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

AGED; ASPIRIN; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; DECISION MAKING; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY;

EID: 0031055529     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11606-006-0001-7     Document Type: Article

References (17)

1. McKee M, Clarke A. Guidelines, enthusiasms, uncertainty, and the limits to purchasing. BMJ. 1995;310:101-4.
2. Woolf SH. Practice guidelines: a new reality in medicine. Arch Intern Med. 1993;153:2646-55.
3. ACC/AHA Task Force. Guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction). J Am Coll Cardiol. 1990;16:249-92.
4. McLaughlin TJ, Soumerai SB, Willison D, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction. Evidence for undertreatment in women and the elderly. Arch Intern Med. 1996;156:799-805.
5. Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care for Medicare patients with acute myocardial infarction: four-state pilot study from the Cooperative Cardiovascular Project. JAMA. 1995;273:1509-14.
6. ISIS-2. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988;2:349-60.
7. GISSI. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarcto Miocardico (GISSI). Lancet. 1986;1:397-402.
8. Gore JM, Granger CB, Simoons ML, et al. Stroke after thrombolysis: mortality and functional outcomes in the GUSTO-I trial. Circulation. 1995;92:2811-8.
9. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-82.
10. Cook DW, Guyatt GH, Alemayehu E, et al. Factors influencing physicians' decisions on caring for an incompetent elderly patient: an international study. Can Med Assoc J. 1991;145:847-952.
11. Cook DJ, Guyatt GH, Jaeschke R, et al. Determinants in Canadian health care workers of the decision to withdraw life support from the critically ill. JAMA. 1995;273:703-8.
12. Callahan CM, Hendrie HC, Tierney WM. Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med. 1995;122:422-9.
13. Hanson LC, Danis M. Use of life-sustaining care for the elderly. J Am Geriatr Soc. 1991;39:772-7.
14. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of coexistent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement: comorbidity and outcomes after hip replacement. Med Care. 1993;31:141-54.
15. Liang KY, Zeger SK. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
16. Moss AH, Stocking CB, Sachs GA, Siegler M. Variation in the attitudes of dialysis unit medical directors toward decisions to withhold and withdraw dialysis. J Am Soc Nephrol. 1993;4(2):229-34.
17. Pearlman RA, Inui TS, Cater WB. Variability in physician bioethical decision-making. A case study of euthanasia. Ann Intern Med. 1982;97:420-5.